Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

VALVOLINE CLEAR CUT OIL

NFPA

PRODUCT USE

Metalworking fluid additive.

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

EMERGENCY OVERVIEW

RISK

Irritating to eyes.

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  The material has NOT been classified as "harmful by ingestion". This is because of the lack of corroborating animal or human evidence. The material may still be damaging to the health of the individual, following ingestion, especially where pre-existing organ (e.g. liver, kidney) damage is evident. Present definitions of harmful or toxic substances are generally based on doses producing mortality (death) rather than those producing morbidity (disease, ill-health). Gastrointestinal tract discomfort may produce nausea and vomiting. In an occupational setting however, unintentional ingestion is not thought to be cause for concern.  

EYE

  This material can cause eye irritation and damage in some persons.  

SKIN

  The material is not thought to produce adverse health effects or skin irritation following contact (as classified using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable gloves be used in an occupational setting.  Entry into the blood-stream, through, for example, cuts, abrasions or lesions, may produce systemic injury with harmful effects. Examine the skin prior to the use of the material and ensure that any external damage is suitably protected.  

INHALED

  The material is not thought to produce adverse health effects or irritation of the respiratory tract (as classified using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable control measures be used in an occupational setting.  

CHRONIC HEALTH EFFECTS

  There has been some concern that this material can cause cancer or mutations but there is not enough data to make an assessment.  Limited evidence suggests that repeated or long-term occupational exposure may produce cumulative health effects involving organs or biochemical systems.  There is some evidence that inhaling this product is more likely to cause a sensitization reaction in some persons compared to the general population.  There is limited evidence that, skin contact with this product is more likely to cause a sensitization reaction in some persons compared to the general population.  Long term exposure to morpholine and some of its congeners may produce liver and kidney damage. Obvious evidence of chronic nasal irritation and inflammation and ocular injury (including retinal degeneration, corneal irritation, uveitis and corneal damage) has been documented in rats exposed to 150 ppm, 6 hours/day, 5 days/week for 104 weeks. Earlier reports linking exposure to morpholine with an increased incidence of hepatocellular carcinoma and pulmonary angiosarcoma, probably resulted from exposure to the carcinogenic contaminant, N-nitrosomorpholine. It must be noted, however, that there is a potential to convert morpholine, a secondary amine), in the body, to the potentially carcinogenic N-  nitros-morpholine. N-nitroso-compounds represent a major class of important chemical carcinogens and mutagens. The induction of tumours by single doses of these substances testify to their potency. Whilst it is difficult to extrapolate animal carcinogenicity data to humans, such data strongly suggests that these compounds are human carcinogens. As a rule the N-nitrosamines as a group are carcinogenic in a multitude of organs and tissues. This is also true for the individual N-nitrosamines where the tumour localisation does not depend only on the kind of nitrosamine but also the species and dose. Mostly, however, a preferred target organ (or even several) can be identified. This is frequently the liver.  One ingredient of the product has caused skin sensitization reactions, shown as localized reddening and hives, or may produce respiratory sensitization characterized by asthma-  like symptoms and runny nose.